Free Trial
OTCMKTS:RGIN

Regenicin (RGIN) Stock Price, News & Analysis

Regenicin logo
$0.0001 +0.00 (+∞)
As of 06/27/2025 02:30 PM Eastern

About Regenicin Stock (OTCMKTS:RGIN)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0001
Volume
50,000 shs
Average Volume
50,000 shs
Market Capitalization
$16.58 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

Receive RGIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regenicin and its competitors with MarketBeat's FREE daily newsletter.

RGIN Stock News Headlines

History
Regenicin, Inc. (RGIN)
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
LGBT+ History Month - Teaching Resources
History of Walmart: Timeline and Facts
See More Headlines

RGIN Stock Analysis - Frequently Asked Questions

Regenicin's stock was trading at $0.0001 on January 1st, 2025. Since then, RGIN stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here
.

Regenicin Inc. (OTCMKTS:RGIN) issued its quarterly earnings data on Wednesday, August, 19th. The company reported $0.00 earnings per share for the quarter.

Shares of RGIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Regenicin investors own include Energous (WATT), Cheniere Energy (LNG), Vital Therapies (VTL), Xerox (XRX), Allergan (AGN) and Leafbuyer Technologies (LBUY).

Company Calendar

Last Earnings
8/19/2020
Today
6/30/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:RGIN
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$16.58 thousand
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:RGIN) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners